
BiomEdit, an Indiana-based medical firm, innovates in probiotics and microbial medicines for unmet animal health needs.
Founded in Fishers, Indiana, BiomEdit is a pioneering medical organization dedicated to discovering, designing, and developing innovative probiotics, microbiome-derived bioactives, and engineered microbial medicines. The company's core mission is to address unmet needs in animal health, aiming to create impactful solutions for significant challenges in animal agriculture. BiomEdit's vision revolves around leveraging cutting-edge microbiome science to enhance animal well-being and productivity.
BiomEdit's notable affiliates include leading scientists and industry experts in microbiome research and animal health. The company has attracted significant interest from investors focused on biotechnology and agricultural innovation. Key achievements include the successful development of several novel microbial treatments that have shown promising results in improving animal health outcomes. BiomEdit's work has had a substantial impact on advancing the field of animal health, contributing to more sustainable and effective agricultural practices.

Native Microbials

AnimalBiome
animalbiome.com

Petri Bio
petribio.com

Microbial Machines

AgThera
agthera.com

Bactana
bactana.com

Biomilitus

Scioto Biosciences

Federation Bio
federation.bio

MarvelBiome
marvelbiome.com

Microbiome Therapeutics

Holobiome
holobiome.org

Microbion
microbioncorp.com

Luca Biologics
seedhealth.com

Synbiotic Health
Companies similar to BiomEdit include Native Microbials, AnimalBiome, Petri Bio and Microbial Machines.
BiomEdit was founded in 2022.
BiomEdit's headquarters is located in Fishers, IN, US.
BiomEdit's most recent funding round was for $4.5M (USD) in November 2023.
As of Nov 2, 2023, BiomEdit has raised a total of $44.5M (USD).
BiomEdit has 36 employees as of Feb 4, 2024.